216 related articles for article (PubMed ID: 12361958)
21. Molecular and functional characterization of human P2X(2) receptors.
Lynch KJ; Touma E; Niforatos W; Kage KL; Burgard EC; van Biesen T; Kowaluk EA; Jarvis MF
Mol Pharmacol; 1999 Dec; 56(6):1171-81. PubMed ID: 10570044
[TBL] [Abstract][Full Text] [Related]
22. Allosteric control of gating and kinetics at P2X(4) receptor channels.
Khakh BS; Proctor WR; Dunwiddie TV; Labarca C; Lester HA
J Neurosci; 1999 Sep; 19(17):7289-99. PubMed ID: 10460235
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
24. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors.
Gomes DA; Song Z; Stevens W; Sladek CD
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R940-9. PubMed ID: 19625689
[TBL] [Abstract][Full Text] [Related]
25. Conserved lysin and arginin residues in the extracellular loop of P2X(3) receptors are involved in agonist binding.
Fischer W; Zadori Z; Kullnick Y; Gröger-Arndt H; Franke H; Wirkner K; Illes P; Mager PP
Eur J Pharmacol; 2007 Dec; 576(1-3):7-17. PubMed ID: 17764672
[TBL] [Abstract][Full Text] [Related]
26. Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors.
Seyffert C; Schmalzing G; Markwardt F
Curr Top Med Chem; 2004; 4(16):1719-30. PubMed ID: 15579104
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species potentiate the P2X2 receptor activity through intracellular Cys430.
Coddou C; Codocedo JF; Li S; Lillo JG; Acuña-Castillo C; Bull P; Stojilkovic SS; Huidobro-Toro JP
J Neurosci; 2009 Sep; 29(39):12284-91. PubMed ID: 19793987
[TBL] [Abstract][Full Text] [Related]
28. Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells.
Koshimizu TA; Van Goor F; Tomić M; Wong AO; Tanoue A; Tsujimoto G; Stojilkovic SS
Mol Pharmacol; 2000 Nov; 58(5):936-45. PubMed ID: 11040040
[TBL] [Abstract][Full Text] [Related]
29. Subtype-specific mechanisms for functional interaction between α6β4* nicotinic acetylcholine receptors and P2X receptors.
Limapichat W; Dougherty DA; Lester HA
Mol Pharmacol; 2014 Sep; 86(3):263-74. PubMed ID: 24966348
[TBL] [Abstract][Full Text] [Related]
30. ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors.
Hausmann R; Bodnar M; Woltersdorf R; Wang H; Fuchs M; Messemer N; Qin Y; Günther J; Riedel T; Grohmann M; Nieber K; Schmalzing G; Rubini P; Illes P
J Biol Chem; 2012 Apr; 287(17):13930-43. PubMed ID: 22378790
[TBL] [Abstract][Full Text] [Related]
31. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
[TBL] [Abstract][Full Text] [Related]
32. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons.
Tsuda M; Koizumi S; Kita A; Shigemoto Y; Ueno S; Inoue K
J Neurosci; 2000 Aug; 20(15):RC90. PubMed ID: 10899177
[TBL] [Abstract][Full Text] [Related]
33. Heteromultimeric P2X(1/2) receptors show a novel sensitivity to extracellular pH.
Brown SG; Townsend-Nicholson A; Jacobson KA; Burnstock G; King BF
J Pharmacol Exp Ther; 2002 Feb; 300(2):673-80. PubMed ID: 11805232
[TBL] [Abstract][Full Text] [Related]
34. Cross-inhibition between nicotinic acetylcholine receptors and P2X receptors in myenteric neurons and HEK-293 cells.
Decker DA; Galligan JJ
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1267-76. PubMed ID: 19342512
[TBL] [Abstract][Full Text] [Related]
35. Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
Rettinger J; Schmalzing G
J Biol Chem; 2004 Feb; 279(8):6426-33. PubMed ID: 14625300
[TBL] [Abstract][Full Text] [Related]
36. Identification of a domain involved in ATP-gated ionotropic receptor subunit assembly.
Torres GE; Egan TM; Voigt MM
J Biol Chem; 1999 Aug; 274(32):22359-65. PubMed ID: 10428806
[TBL] [Abstract][Full Text] [Related]
37. Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization.
Koshimizu T; Tomić M; Van Goor F; Stojilkovic SS
Mol Endocrinol; 1998 Jul; 12(7):901-13. PubMed ID: 9658396
[TBL] [Abstract][Full Text] [Related]
38. The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones.
Thomas S; Virginio C; North RA; Surprenant A
J Physiol; 1998 Jun; 509 ( Pt 2)(Pt 2):411-7. PubMed ID: 9575290
[TBL] [Abstract][Full Text] [Related]
39. Desensitization of the P2X(2) receptor controlled by alternative splicing.
Brändle U; Spielmanns P; Osteroth R; Sim J; Surprenant A; Buell G; Ruppersberg JP; Plinkert PK; Zenner HP; Glowatzki E
FEBS Lett; 1997 Mar; 404(2-3):294-8. PubMed ID: 9119082
[TBL] [Abstract][Full Text] [Related]
40. Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP).
Burgard EC; Niforatos W; van Biesen T; Lynch KJ; Kage KL; Touma E; Kowaluk EA; Jarvis MF
Mol Pharmacol; 2000 Dec; 58(6):1502-10. PubMed ID: 11093790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
